Medipharm Labs Corp (LABS.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Sales | 10,350 | 9,771 | 9,131 | 8,505 | 9,583 |
| Cost of Goods | 6,932 | 7,120 | 6,935 | 6,088 | 8,728 |
| Gross Profit | 3,418 | 2,651 | 2,196 | 2,417 | 855 |
| Operating Expenses | 5,991 | 6,376 | 4,626 | 6,772 | 8,484 |
| Operating Income | -2,573 | -3,725 | -2,430 | -4,355 | -7,629 |
| Interest Expense | 210 | 110 | 101 | 149 | 110 |
| Other Income | 200 | 224 | -707 | 174 | 5,036 |
| Pre-tax Income | -2,583 | -3,611 | -3,238 | -4,330 | -2,703 |
| Income Tax | N/A | N/A | -273 | -3 | 0 |
| Net Income Continuous | -2,583 | -3,611 | -2,965 | -4,327 | -2,703 |
| Net Income | $-2,583 | $-3,611 | $-2,965 | $-4,327 | $-2,703 |
| EPS Basic Total Ops | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 |
| EPS Basic Continuous Ops | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 |
| EPS Diluted Total Ops | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 |
| EPS Diluted Continuous Ops | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 |
| EBITDA(a) | $-1,642 | $-2,711 | $-2,420 | $-3,564 | $-1,901 |